As families come together to celebrate the holiday season, the shared time can be an opportunity to talk about health. Although genetics may not be the liveliest of holiday dinner topics, family gatherings represent a unique opportunity to raise awareness about the important role that genetics can play in familial cancer risk, reduction and diagnosis.
At Seattle Cancer Care Alliance (SCCA), genetic testing is a vital part of cancer care. Genetic information can influence and guide cancer treatment—especially a type of genetic testing called “cascade testing,” which helps identify people at risk for a hereditary condition. SCCA genetic counselor Lorraine Naylor joins us to discuss Cascade testing, sometimes known as “cascade screening,” which refers to the process of testing biological relatives of an individual who has tested positive for a hereditary cancer syndrome to see if they too are positive.
A: Cascade testing occurs when a family member has already tested positive for a genetic mutation that increases cancer risk. Usually, the first person testing in a family has had a cancer diagnosis. Once we identify the genetic cause for that cancer diagnosis, we know exactly what to look for in other family members. Cascade testing is very clear-cut as far as results go because we know exactly what we are looking for. The results truly are a yes or no answer.
A: Any family members of anyone who has tested positive for a hereditary cancer mutation or syndrome. Children, parents, cousins – anyone.
A: In most cases, we don’t test minors. There are a few exceptions for two or three genes that carry a risk of childhood cancer. In that case, it becomes a personal decision for parents. In most situations, we offer genetic testing to anyone over the age of 18.
Keep in mind that the majority of screening recommendations don’t necessarily start until ages 20 to 25 at the earliest. Some gene mutations don’t change a person’s screening recommendations until age 30 to 40. For example, recommendations for women with BRCA1 and BRCA2 mutations are to start having breast MRIs at 25 and to add in mammograms at age 30. Recommendations for people with Lynch syndrome are to start colonoscopies between 20 and 25 years old. These are the two earliest-onset recommendations for the most common hereditary cancer syndromes that we see.
So if you wouldn’t change anything or do anything differently until you’re 25, you may not want to test until you’re 25.
A: Cascade testing has been around for as long as we’ve been doing genetic testing. Fifteen or 20 years ago, genetic testing in general was more abstract; now it’s becoming a standard of care so more people are getting genetic testing and more people are learning they are at risk, which results in more people getting cascade testing.
A: It can be done by most labs, but if you want to make sure it’s done appropriately, I recommend going to a genetics provider. We run into lots of people who had genetic testing ordered by other providers and it ends up not being the right test. It can cost a lot more if a comprehensive test is incorrectly ordered instead of a specific test needed for cascade testing.
A: Almost always. Cascade testing is very rarely not covered by insurance. People think cost is a barrier but some labs offer discounted or even free cascade testing.
A: Cascade testing shows us more accurately what cancers someone is at risk for. Learning what you are at increased risk for helps us to change screening recommendations to find cancers as early as possible, or in some cases even prevent it.
A: Some people don’t want to know that information. If they learn their mom has a BRCA mutation, they may not be ready to get tested themselves and potentially deal with the knowledge that they are at increased risk. As genetic counselors, we point out that having information gives you more options, but we also make sure and discuss all of the pros and cons of genetic testing, so each individual can make the decision that is best for them.
Get once-a-month updates about proton therapy, including science and medicine news, survivor stories, staff profiles and more.
Your gift will be triple-matched, making three times the impact for lifesaving research.
For the Media